Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-25-000262
Filing Date
2025-06-26
Accepted
2025-06-26 16:55:36
Documents
1
Period of Report
2025-06-24

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3803
  Complete submission text file 0001610717-25-000262.txt   5363
Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
Morrison Scott W (Reporting) CIK: 0001662426 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38915 | Film No.: 251081095

Mailing Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 5000 SHORELINE CT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Issuer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)